by John Conrad | Dec 18, 2024 | iBIO News
As Illinois’ life sciences industry continues its remarkable growth trajectory, iBIO President and CEO John Conrad and iBIO Board Chair Ken Johnson, Senior Vice President of Global Development and Medical Affairs at Xeris Pharmaceuticals, sat down to discuss the...
by John Conrad | Dec 2, 2024 | iBIO News
The newly released TECONOMY/BIO report, “The U.S. Bioscience Economy: Driving Economic Growth and Opportunity in States and Regions,” paints an impressive picture of Illinois’ life sciences industry. The data reveals an industry that’s not just...
by John Conrad | Dec 2, 2024 | iBIO News
The pharmaceutical industry faces a pivotal moment as political shifts introduce new dimensions of uncertainty into our operating environment. The recent election outcomes and potential leadership changes at key health agencies are reshaping the landscape for...
by John Conrad | Nov 14, 2024 | iBIO News
In a significant move to enhance science education across Illinois, the Illinois Biotechnology Innovation Organization (iBIO) has launched its innovative “LabShare” program. This groundbreaking program connects surplus laboratory equipment from iBIO member...
by John Conrad | Nov 13, 2024 | iBIO News
This month’s G2G report features 148 funding opportunities totaling over $500 million in non-dilutive funding for life sciences companies. Through iBIO’s G2G Consulting partnership, members have exclusive access to these comprehensive resources that help...
by John Conrad | Oct 30, 2024 | iBIO News
The path to STEM careers often begins with early exposure and encouragement. For girls in underserved communities, access to engaging STEM education can be transformative, opening doors to future opportunities that might otherwise remain closed. iBIO’s STEMgirls...
